StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cardiol Therapeutics's enterprise value was $72.68M on Nov 11, 2026, against $53.26M a year earlier. Over the last 5 years it ranged from -$39.96M to $156.35M, with a median of $53.26M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$72.68M+58.1%
2025Dec 31, 2025$45.96M-21.1%
2024Dec 31, 2024$58.25M+660.6%
2023Dec 29, 2023$7.66M–
2022Dec 30, 2022-$39.96M-190.3%
2021Dec 31, 2021$44.26M–

More Cardiol Therapeutics figures

See a number that looks wrong?